Literature DB >> 31556692

NUDT15 and TPMT Genetic Polymorphisms Are Related to Azathioprine Intolerance in Chinese Patients with Rheumatic Diseases.

Jing Yang1, Peile Wang1, Zifei Qin1, Mengmeng Jia1, Congmin Zhang1, Xueke Tian1, Yunbo Zheng1, Ailing Zhang1, Xiaojian Zhang1, Shengyun Liu2.   

Abstract

Aims: Azathioprine (AZA) is commonly used to treat autoimmune diseases, but its applications have been limited due to significant adverse effects, particularly leukopenia. The aim of this study was to investigate the associations of NUDT15, TPMT, and inosine triphosphatase (ITPA) polymorphisms with AZA-induced toxicity. Materials and
Methods: A total of 86 Chinese patients with autoimmune diseases were recruited, and the NUDT15*2-*6, TPMT*3C, and ITPA rs7270101 genotypes of these patients were characterized by Sanger sequencing. Sociodemographic data and clinical records over a period of 6 months were also collected.
Results: The TPMT*3C and NUDT15*3 genotypes were significantly associated with AZA-induced leukopenia (p = 0.007 and 4.475 × 10-6, respectively). The p-value for the correlation between ITPA rs7270101 and leukopenia was 0.059. In addition, NUDT15*3 was significantly associated with gastrointestinal effects, erythropenia, hypochromia, and thrombocytopenia [p = 0.002, 1.109 × 10-5, 1.653 × 10-7, and 9.110 × 10-6, respectively; allelic odds ratio (95% confidence interval): 5.714 (1.56-20.95), 9.333 (2.96-29.47), 13.18 (4.15-41.87), and 20.13 (3.40-119.18), respectively]. The TPMT*3C genotypes were also significantly associated with gastrointestinal discomfort [p = 0.028, 12.08 (0.71-204.49)], alopecia [p = 2.864 × 10-4, 33 (1.80-606.47)], and hypochromia [p = 0.045, 10.33 (0.61-173.66)].
Conclusion: This study demonstrated that NUDT15*3 and TPMT*3C are both highly predictive genetic markers for AZA-induced toxicity in Chinese populations with rheumatic diseases.

Entities:  

Keywords:  NUDT15; TPMT; azathioprine; genetic polymorphisms; rheumatic diseases

Mesh:

Substances:

Year:  2019        PMID: 31556692     DOI: 10.1089/gtmb.2018.0313

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  4 in total

1.  Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis.

Authors:  Atinuke Aluko; Prabha Ranganathan
Journal:  Methods Mol Biol       Date:  2022

2.  Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study.

Authors:  Zhao-Yang Chen; Yang-Hui Zhu; Ling-Yan Zhou; Wei-Qiao Shi; Zhou Qin; Bin Wu; Yu Yan; Yu-Wen Pei; Ning-Ning Chao; Rui Zhang; Mi-Ye Wang; Ze-Hao Su; Xiao-Jun Lu; Zhi-Yao He; Ting Xu
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

Review 3.  Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations.

Authors:  Kanyarat Khaeso; Sariya Udayachalerm; Patcharee Komvilaisak; Su-On Chainansamit; Kunanya Suwannaying; Napat Laoaroon; Pitchayanan Kuwatjanakul; Nontaya Nakkam; Chonlaphat Sukasem; Apichaya Puangpetch; Wichittra Tassaneeyakul; Nathorn Chaiyakunapruk
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810

4.  Bone marrow inhibition induced by azathioprine in a patient without mutation in the thiopurine S-methyltransferase pathogenic site: A case report.

Authors:  Xiao-Shuang Zhou; Yuan-Yue Lu; Yan-Fang Gao; Wen Shao; Jia Yao
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.